A new combination of antiviral drugs did not improve clinical outcomes in hospitalized patients with severe influenza, warranting further investigation into new therapeutic strategies, according to a recent clinical trial.
Recent advances from Northwestern investigators have powered a new, deeper understanding of Parkinson’s disease that could pave the way to a disease-modifying treatment.
Treating breast tumors alongside distant metastases did not improve outcomes in women with stage IV breast cancer, according to a new study.
Robert Kushner, MD, ’80, ’82 GME, was honored for a study published in NEJM with a 2022 Top 10 Clinical Research Achievement Award.
A novel combination treatment approach extended survival in mice with pancreatic cancer, demonstrating a potential second-line therapy for patients.
A new study shines a spotlight on an important but often overlooked matter of the heart — optimizing cardiovascular health before getting pregnant.
A new study suggests that one contributor to inequities in pregnancy and cardiovascular outcomes may be the stress created by police violence occurring in Black women’s neighborhoods.
Sequencing known cardiac arrythmia genes in more than 20,000 people without an indication for genetic testing identified pathogenic variants in nearly one percent of individuals.
Northwestern investigators have discovered that dopamine signaling in the dorsomedial striatum promotes the development of compulsive behaviors, according to findings published in Current Biology.
Northwestern Medicine investigators continue to study the COVID-19 pandemic, from the biological mechanisms of disease and infection patterns to the pandemic’s impact on women and sexual and gender minorities.